Conférences  >  Médecine & Soins de Santé  >  Cancérologie

Sélecionner un pays
TOUS LES PAYS (33)
1
International Conference on Cancer and Oncology Research
30 mai 2024 - 31 mai 2024 • Rome, Italie
Organisateur:
Spectus Conferences
Résumé:
The Organizing Committee of International Conference on Cancer and Oncology Research invite you to participate in the Cancer Conference, which will be held during May 30-31, 2024 at Rome, Italy The main theme of conference is “Exploring the Recent Research and Advancements in Cancer and Oncology Research”. This Conference will provide a unique opportunity for researchers, healthcare practitioners, paramedics and trauma care specialists from around the world to communicate and share innovative thoughts and practices designed to optimize patient care.
Contact:
Tél.: [03023084943];     Email.: spec-cancer@spectusconferences.org
Sujets:
Skin Cancers Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Cancer Therapy & Treatments Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Antibody-based Therapeutics Against Cancer Radiation Oncology
Identifiant de l'évènement:
1585185
2
EACR-EuCanImage Workshop — Trustworthy AI in Multi-Country Cancer Imaging
10 jui 2024 • Rotterdam, Pays-Bas
Organisateur:
The European Association for Cancer Research (EACR) & EuCanImage
Résumé:
On the morning before our 2024 Congress begins, we are holding a specialised and free-to-attend EuCanImage workshop. Taking place between 09:00 and 14:00 CEST on Monday 10 June, this session will focus on the clinical and technical considerations of trustworthy Artificial Intelligence in multi-country oncology imaging, using experiences from The H2020 EuCanImage project as a basis for discussion.
Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, cancer research techniques, oncology imaging, artificial intelligence, data collection, large-scale data analysis, breast cancer data, liver cancer data, colon cancer data, rectum cancer data, colorectal cancer data, radiomics, deep learning, bioinformatics, biostatistics, diagnostics and biomarkers, prevention and early detection, metastasis, treatment response, clinical applications, technical considerations.
Identifiant de l'évènement:
1614562
3
EACR2024 — EACR Congress 2024: Innovative Cancer Science
10 jui 2024 - 13 jui 2024 • Rotterdam, Pays-Bas
Organisateur:
The European Association for Cancer Research
Résumé:
The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations. The programme includes cutting-edge scientific talks on various topics, industry symposia and spotlights, educational sessions, meet-the-expert panels, career discovery sessions, and a vast poster display. Topics to be covered include: modulating the tumour microenvironment; drug resistance; mechanism-based clinical trials; precision cancer medicine in the post-genomic era; senescence, dormancy, and related cell states; metabolism and cancer; cell-based therapies; spatial analysis of tumours/spatial transcriptomics; mechanical forces of cancer; mechanisms of tumour metastases; targeting mitochondria in cancer; liquid biopsies; drugging tumour suppressor genes; imaging the tumour microenvironment; making cold tumours hot; drugging the RAS Pathway; modeling cancer; and aging, gender, and cancer.
Contact:
Event Organisers: New Way Management;     Email.: eacr@newway-management.com
Sujets:
cancer research, cancer research conference, oncology, cancer models, liquid biopsies, tumour microenvironment, tumour metastasis, cancer metabolism, cancer cell states, cell-based therapies, drug resistance, genomics, spatial transcriptomics
Identifiant de l'évènement:
1583223
4
DEGRO 2024 — 30th Congress of the German Society for Radiation Oncology
13 jui 2024 - 15 jui 2024 • Kassel, Allemagne
Organisateur:
Deutsche Gesellschaft für Radioonkologie e.V. (German Society for Radiation Oncology)
Résumé:
At the annual congress of the German Society of Radiation Oncology (DEGRO), all those working in radiation oncology have the opportunity to discuss all aspects important for the development of radiation oncology in a concentrated form and thus come to a broad exchange of knowledge.
Contact:
Kongressorganisation;     Tél.: [+49 3643 2468-126];     Email.: degro-registrierung@KUKM.DE
Sujets:
radiooncology, radiotherapy, nuclear medicine, oncology, radiology, radiation, hematology, medicine, nuclear physicians, medical technologist for radiology
Identifiant de l'évènement:
1565904
5
HOHH0624 — Hämato Onko Refresher Hamburg
21 jui 2024 - 22 jui 2024 • Hambourg, Allemagne
Organisateur:
FomF GmbH - Forum für medizinische Fortbildung
Résumé:
Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Hamburg & via Livestream, 21.-22.06.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!
Contact:
Tél.: [+49 (0) 6192 47072 00];     Email.: info@fomf.de
Identifiant de l'évènement:
1573989
6
EACR Early-Career Researchers' Conference
25 jui 2024 - 26 jui 2024 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research
Résumé:
This highly interactive online meeting for early-career researchers focuses on career development. It will cover all the topics that our ECR members tell us they need – such as leadership skills, personal growth, translating research, and bridging the gap between academia and industry – and will offer plenty of opportunities for delegates to speak directly with the experts. The target audience for this conference is: scientists in the early phase of their career who want to develop a career in cancer research. The programme is tailored for scientists in the process of starting their independent path, as well as for researchers engaging with the clinical and industrial applications of their work.
Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, cancer research careers, oncology, oncology careers, career guidance, leadership skills, cancer research leadership, personal development, translating research, working in academia, working in industry, science sustainability, grant writing, science creativity, science diversity, personal brands, translational cancer research, basic cancer research, preclinical cancer research
Identifiant de l'évènement:
1600150
Sujets apparentés:
7
ESMO GI 2024 — ESMO Congress on Gastrointestinal Cancers 2024
26 jui 2024 - 29 jui 2024 • Munich, Allemagne
Organisateur:
European Society for Medical Oncology (ESMO)
Résumé:
Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present very impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.

In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern. The ESMO Gastrointestinal Cancers Congress will provide global visibility for original clinical and translational research.

Contact:
Tél.: [+41 (0)91 973 19 62];     Email.: gicongress@esmo.org
Sujets:
Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer, Pancreatic Cancer, Biliary Tract Cancer, Neuroendocrine Tumors, Colon Cancer, Rectal Cancer, GIST, Anal Cancer, Gastrointestinal Cancers
Identifiant de l'évènement:
1569510
8
11th ISCaM Meeting
03 jul 2024 - 05 jul 2024 • Bruxelles, Belgique
Résumé:
Cancers are characterized by a high metabolic heterogeneity allowing cancer cells to survive and proliferate under microenvironment- and therapy-induced stress conditions. Recent technical developments have revealed the spatially- and temporally-resolved complexity of the metabolic networks within tumors and its role in tumor initiation and progression. The 11th ISCaM meeting, in Brussels (Belgium), will gather renowned experts in the cancer metabolism field to discuss the most recent knowledge related to metabolic alterations in cancer, and how this can be translated to the clinics to treat cancer patients.
Sujets:
Immunometabolism, Lipid metabolism and ferroptosis, Metabolism and therapy resistance, Tumor microenvironment and disease progression, Epigenetics, circadian clock and cancer metabolism, Tumor acidosis and imaging
Identifiant de l'évènement:
1602413
9
12th Annual Immuno-Oncology Summit 2024
07 aou 2024 - 09 aou 2024 • Philadelphia, États-Unis
Organisateur:
CHI
Résumé:
In the past 11 years, CHI’s Immuno-Oncology Summit has grown to be the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology. Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives. We look forward to seeing you in Philadelphia this August 7th-9th, where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.
Contact:
Tél.: [781.972.5400];     Email.: chi@healthtech.com
Sujets:
In the past 11 years, CHI's Immuno-Oncology Summit has grown to be the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology. Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives. We look forward to seeing you in Philadelphia this August 7th-9th, where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.
Identifiant de l'évènement:
1619605
Sujets apparentés:
10
EMBO | FEBS Lecture Course — Molecular mechanisms in signal transduction and cancer
18 aou 2024 - 26 aou 2024 • Spetses, Grèce
Organisateur:
European Molecular Biology Organization – EMBO
Identifiant de l'évènement:
1578704
Sujets apparentés:
11
The Mathematics of the Hallmarks of Cancer
19 aou 2024 - 23 aou 2024 • The Fields Institute, Toronto, Ontario, Canada
Organisateur:
Fields Institute
Résumé:
This workshop aims to showcase the state-of-the-art mathematical and computational models that are in use in mathematical oncology, with a particular focus on the fourteen hallmarks of cancer. New modeling challenges arise from these hallmarks. Some of the hallmarks relate to the characteristics of the cancer cells themselves (sub-cellular and cellular level), while others include more global effects such as blood circulation, the immune response, the effect and role of the microenvironment, mechanical forces, and the microbiome. Matching the biological diversity of the cancer hallmarks, is the diversity of mathematical approaches and techniques that have been used and are in use to give insight into the growth and spread of cancer – for example, continuum and discrete models; ordinary and partial differential equation models; individual-based and agent-based models; hybrid models; deterministic and stochastic approaches; analytical and computational approaches. Many of these processes act on very different spatial and temporal scales. Hence a new integrated multiscale mathematical modeling framework is needed to include new aspects and insights, such as spatial stochastic models and local and non-local partial differential equation models.
Identifiant de l'évènement:
1558092
Sujets apparentés:
12
EUSTM-2024 — 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care
06 sep 2024 - 08 sep 2024 • Online Congress, Virtuel (en ligne)
Organisateur:
European Society for Translational Medicine
Résumé:
The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2024) held in virtual format during 6-8 September, 2024. The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care. EUSTM-2024 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.
Contact:
Tél.: [+43 1 8923 562];     Email.: immuno-2024@eutranslationalmedicine.org
Sujets:
solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, vaccines biological research, diagnostics, biomarkers, clinical care, Immunology, MIcrobiology, life sciences, Molecular Biology, Cancer, Blood Cancers, Breast cancer, Lungs Cancer, Ovarian cancer, GIT cancer, Brain cancer, Genitourinary cancer, prostate cancer, bladder cancer,
Identifiant de l'évènement:
1619591
13
ICPM10 & IWPCT9 — 10th International Conference on Plasma medicine and 9th International Workshop on plasma for cancer treatment
08 sep 2024 - 13 sep 2024 • Portorož, Slovénie
Organisateur:
Jožef Stefan Institute
Résumé:
As in previous editions of the conference, the ICPM will bring together professionals from the fields of plasma, medicine, biology and biochemistry in order to develop a common language, to better define key challenges and open questions and to move toward effective solutions. This time it will be organized jointly with IWPCT covering plasma for cancer therapy on Monday, Sep. 9th. Prior to the conference, the traditional Summer School will take place, starting on the weekend, Sunday, Sep. 8th, and going through mornings from Monday, Sep. 9th to Wednesday, Sep. 11th. Registrations for the summer school will be conducted separately from the registrations for the conference.
Contact:
Email.: icpm10@ijs.si
Sujets:
plasma, medicine, cancer treatment,
Identifiant de l'évènement:
1596812
14
EHMSG 2024 — 37th Workshop of the European Helicobacter and Microbiota Study Group
12 sep 2024 - 14 sep 2024 • Porto, Portugal
Organisateur:
European Helicobacter and Microbiota Study Group
Résumé:
The European Helicobacter and Microbiota Study Group (EHMSG) is a multidisciplinary group composed of representatives from most countries of the EU. It was founded in 1987 by a collaboration of pioneers in the field of Helicobacter and expanded its remit in 2016 to embrace the collective gastrointestinal microbiota. This includes dissemination of medical, scientific and technical information in order to promote health and decrease the burden of digestive diseases.

Each year, EHMSG hosts a conference consisting of a one-day postgraduate course followed by a 2-day workshop.

Contact:
Event Secretariat;     Tél.: [+431405138318];     Email.: workshop@ehmsg.org
Sujets:
Helicobacter, Microbiota, IBD, FMT
Identifiant de l'évènement:
1584991
15
Mathematical Modelling of Cancer Treatments, Resistance, Optimization
16 sep 2024 - 20 sep 2024 • The Fields Institute, Toronto, Ontario, Canada
Organisateur:
Fields Institute
Résumé:
This workshop aims to take a closer look at how mathematical and computational models can help answer clinically relevant questions and enhance multimodal treatments. Currently, a wide range of modelling approaches study cancer and have a crucial role in treatment delivery from answering questions related to cancer biology and treatment efficacy to directly helping with treatment delivery. In this workshop, we would like to bring together clinicians, biomedical experts, experimentalists, and mathematicians to explore some of the relevant questions on multimodal treatment modelling, efficacy, optimization, drug resistance and clinical delivery.
Identifiant de l'évènement:
1558116
Sujets apparentés:
16
ESOI — ESOI Touchdown 2024 Valencia
19 sep 2024 - 21 sep 2024 • Valencia, Espagne
Organisateur:
European Society of Oncologic Imaging
Résumé:
The ESOI Touchdown 2024 event is an annual meeting organized by the European Society of Oncologic Imaging, where participants can follow various lectures by leading scholars and practitioners on oncologic imaging.
Contact:
ESOI Office;     Email.: office@esoi-society.org
Sujets:
radiology, oncologic imaging, oncology
Identifiant de l'évènement:
1611958
17
EACR Next Generation Cancer Therapies
24 sep 2024 - 25 sep 2024 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients. The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development. Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.
Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, therapeutic targets, cancer drug discovery, drug discovery approaches, new technical approaches to cancer therapeutics, early clinical development, small molecule technology, phenotypic screens, covalent fragment screens, degrader technology, PROTAC, molecular glue, peptide technology, oral cyclic peptide inhibitors, antibody technology, antitumour approaches, antibody drug conjugates, targeting RAS, targeting mutant p53.
Identifiant de l'évènement:
1616924
18
2024 RNA Therapeutics Symposium - Unlocking RNA's Potential in Medicine
25 sep 2024 - 27 sep 2024 • Porto, Portugal
Organisateur:
kenes exhibitions
Résumé:
The RNA Therapeutics Symposium aims to harness the transformative potential of RNA technology for a broader spectrum of cancer therapeutics. Bringing together a diverse array of experts, including RNA biologists, systems analysts, immunologists, and drug development specialists, this event fosters a collaborative environment. It facilitates the exchange of cutting-edge research, the development of a unified scientific lexicon, and the acceleration of research and development efforts in RNA therapeutics.
Contact:
Tél.: [+972 74 745 7435];     Email.: skrein@kenes-exhibitions.com
Sujets:
RNA Therapeutics RNA Vaccines  RNA medicines RNA Manufacturing RNA technologies immunology Biotech Cancer
Identifiant de l'évènement:
1618059
19
ADO 2024 — 34. Deutscher Hautkrebskongress
25 sep 2024 - 28 sep 2024 • Würzburg, Allemagne
Organisateur:
Conventus Congressmanagement & Marketing GmbH
Contact:
Conventus Congressmanagement & GmbH;     Email.: conferencemarketing@conventus.de
Identifiant de l'évènement:
1358778
Sujets apparentés:
20
The Ecology and Evolution of Cancer
30 sep 2024 - 04 oct 2024 • The Fields Institute, Toronto, Ontario, Canada
Organisateur:
Fields Institute
Résumé:
This workshop explores research in methods aimed at connecting mathematical models of cancer evolution and clinical data. It focuses on ecology and evolution of cancer. Traditionally, ecology and evolution have been the most “mathematical” (and perhaps the first mathematical) areas of biology. Mathematical contributions to these fields made in the 20th century are now fundamental parts of scientific knowledge. More recently, methods of ecology and evolution have found their way into oncology, bridging traditional molecular biology and mathematics including stochastic processes, dynamical systems, and nonlinear partial differential equations. New biological challenges lead to difficult mathematical problems and beautiful solutions, which are both innovative mathematically and impactful from the point of view of public health. These will be the focus of the proposed workshop .
Identifiant de l'évènement:
1558106
Sujets apparentés:
21
EACR Cancer Metabolism
08 oct 2024 - 10 oct 2024 • Bilbao, Espagne
Organisateur:
The European Association for Cancer Research
Résumé:
This conference will gather top experts in the field of cancer metabolism to discuss the metabolic alterations in tumours and how we can exploit this to treat cancer. Topics to be covered include: metabolic reprogramming in cancer beyond anabolism, metabolic transformation in cancer cells, metabolic signalling in cancer, metabolic cross-talk in the tumour microenvironment, metabolic regulation of gene expression, immune cell metabolism in cancer, nucleotide metabolism and cancer, metabolic approaches to cancer therapy, and systemic metabolic changes and their effects on cancer progression. The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of cancer metabolism.
Contact:
Conference Officer: Chris Iliffe;     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org
Sujets:
cancer metabolism, adaptations of cancer, tumour biology, tumour vulnerabilities, cancer cell biology, stromal cell biology, metabolic cell wiring, cell anabolism, molecular properties of cancer cells, cancer genomics, cancer cell signalling, nutrient signalling, cancer metabolic alterations, metabolic cross-talk, the tumour microenvironment, the tumour macroenvironment, gene expression, immune cell metabolism, metabolic approaches to cancer therapy, cancer progression, cancer research, oncology
Date limite de soumission des résumés:
05 aou 2024
Identifiant de l'évènement:
1600181
22
Mathematical Modelling of Tumour Immune Dynamics and Immunotherapies
14 oct 2024 - 18 oct 2024 • The Fields Institute, Toronto, Ontario, Canada
Organisateur:
Fields Institute
Résumé:
Immunotherapies have revolutionized treatments for several types of cancers, but have been met with clinical trial failures in others. The idea of eliciting an immune response against a tumour is old, but we are only just beginning to harness the potential of the immune system to treat both solid and liquid tumours. To improve immunotherapeutic approaches requires understanding how the immune system interacts around and within a tumour, allowing us to establish effective immunotherapeutic protocols. Mathematical modelling can help identify the mechanisms at the heart of immunotherapeutic efficacy and design successful therapeutic regimens. Close collaboration between experimentalists, clinicians, and quantitative researchers in academia and industry is required to forward models for implementation. This workshop will focus on tightening the links between researchers in different fields to fuel immunotherapy success.
Identifiant de l'évènement:
1558030
Sujets apparentés:
23
EANO 2024 — 19th Meeting of the European Association of Neuro-Oncology
17 oct 2024 - 20 oct 2024 • Glasgow, Royaume-Uni
Résumé:
As usual, the annual EANO meeting will kick off with an Educational Day on Thursday, October 17 and the main programme will commence on Friday, October 18. The congress encourages exchange and collaboration between all relevant disciplines: Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology and Radiation Oncology as well as Nursing and other Allied Health Professionals, and aims to bring together scientific and clinical expertise and research to bridge gaps in our understanding and management of central nervous system tumours. EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central nervous system. The successful 2023 EANO meeting in Rotterdam attracted more than 1000 participants from all continents and was very highly rated!
Identifiant de l'évènement:
1602425
Sujets apparentés:
24
Oncology Research 2024 — 4th European Congress on Cancer and Oncology Research
28 oct 2024 - 29 oct 2024 • Rome, Italie
Organisateur:
Coalesce Research Group
Résumé:
We are glad to announce the 4thEuropean Congress on Cancer and Oncology Research on October 28-29, 2024 at Rome, Italy with the theme “Breaking Barriers: Collaborative Approaches in Cancer Research”. Our Aim is to bring global scientists/ researchers and business professionals to one platform. Oncology Research 2024 includes the series of B2B & B2C meetings, Oral Talks, Poster Presentations, and Workshops & Exhibitions by Industries, Academicians, Professors, and Young Forum Researchers & Students.by providing collaboration spaces and break-out rooms with tea and lunch for speakers, and delegates between sessions with invaluable networking time for you.
Contact:
Tél.: [1-718-543-9362];     Email.: sarahlivingstone178@gmail.com
Sujets:
Cells and Cell Structure Cancer Systems Biology Sarcoma Colorectal Cancer Breast-cancer Blood cancer Skin cancer Gynecologic Cancer Head and Neck Cancer Genetic Cancer Nanotechnology in cancer Organ Specific Cancer Pediatric Oncology Medical Oncology Radiation Oncology Neuro Oncology Tissue regeneration and Oncology Cancer Epidemiology Cancer Treatment & Therapy Covid & Its impact on cancer Cancer Immunotherapies Cancer Biomarkers Cancer Metastasis Cancer drugs Market Tumor Virology and Immunology Radiology and Medical Imaging Cancer Chemotherapy and Pharmacology
Identifiant de l'évènement:
1593409
25
ISMM28 — The 28th International Symposium on Molecular Medicine
08 nov 2024 - 10 nov 2024 • Guangzhou, Chine
Organisateur:
Spandidos Publications
Résumé:
ISMM28 will focus on the latest research findings and cutting-edge technologies in the field of molecular medicine, with leading experts and scholars gathering from all over the world. ISMM28 creates a broad academic platform where participants will have the opportunity to share their research results, exchange academic views, and discuss the future direction of molecular medicine.
Contact:
Organizing Committee;     Tél.: [+86-15361286025];     Email.: jiangjie@yujiab.com
Sujets:
Molecular medicine, oncology, SCI, academic conferences
Identifiant de l'évènement:
1609425
26
2. LGS — 2. Leipziger Gerinnungssymposium
09 nov 2024 • Leipzig, Allemagne
Organisateur:
Medizinisches Zentrallabor – Abteilung Transfusionsmedizin und Klinische Hämostaseologie, Klinik für Hämatologie, Zelltherapie und Hämostaseologie Bereich Hämostaseologie, MVZ Labor Dr. Reising-Ackermann und Kollegen
Contact:
event lab. GmbH;     Tél.: [0341 30 88 84 62];     Email.: asauerland@eventlab.org
Identifiant de l'évènement:
1616545
27
LION — Leipzig Immune ONcology (LION) Conference
12 nov 2024 - 13 nov 2024 • Leipzig, Allemagne
Organisateur:
Fraunhofer Institute for Cell Therapy and Immunology, University Hospital Leipzig
Résumé:
The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Hospital Leipzig.
Contact:
Fraunhofer Institute for Cell Therapy and Immunology, Jens Augustin;     Email.: info@lion-conference.com
Sujets:
oncology, immunotherapy, gene therapy, cell therapy
Identifiant de l'évènement:
1618639
Sujets apparentés:
28
LION — Leipzig Immune ONcology (LION) Conference
12 nov 2024 - 13 nov 2024 • Leipzig, Allemagne
Organisateur:
Fraunhofer Institute for Cell Therapy and Immunology; Leipzig University Cancer Center (UCCL)
Résumé:
The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.
Contact:
Conference office: event lab. GmbH;     Tél.: [+49 341 30 8884-72];     Email.: info@lion-conference.com
Sujets:
cancer immuno therapy, immune oncolocgy
Identifiant de l'évènement:
1619678
Sujets apparentés:
29
EACR Liquid Biopsies
12 nov 2024 - 14 nov 2024 • Lyon, France
Organisateur:
The European Association for Cancer Research
Résumé:
Our popular Liquid Biopsies series returns for its fourth edition to bring together a slate of recognised experts who will explore how complex multi-modal liquid biopsy assays could be taken from the laboratory into clinical practice. Topics to be covered include the implementation of liquid biopsy in clinical trials, the various applications for CTCs, the basic biology of biomarker discovery, new techniques enhancing liquid biopsy, the integration of multiple blood-based analytes for multi-modal biomarkers, and how artificial intelligence can be applied to the field. This conference is suitable for a wide audience including translational scientists, researchers working in genetics, biology, molecular pathology, bioengineering, and data science, as well as clinical and non-clinical trainees, primary care physicians, radiologists, patient advocates, and colleagues from industry working in biotechnology, diagnostics, and pharmaceuticals.
Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
liquid biopsy, cancer research, oncology, translational research, clinical trials, clinical practice, early detection of cancer, cancer screening techniques, multi-modal assays, treatment efficacy vs resistance, treatment toxicity, cell-free DNA, cfRNA, CTCs, extracellular vesicles, extracellular proteins, blood-based analytes, AI in cancer detection and screening
Identifiant de l'évènement:
1600193
30
EACR Cancer and Ageing
03 dec 2024 - 04 dec 2024 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Ultimately, the conference seeks to catalyse collaborative efforts to confront the unique challenges posed by cancer in the ageing world, with the overarching goal of improving the quality of life and outcomes for elderly cancer patients. This conference is relevant for a diverse range of researchers, clinicians, and industry professionals. We look forward to being joined by: scientists and academics working in oncology, gerontology, genetics, and related disciplines; clinical oncologists, geriatricians, and other healthcare professionals who play a crucial role in diagnosing, treating, and supporting elderly patients with cancer; and representatives from pharmaceutical companies and biotechnology firms which develop innovative therapies and technologies to combat cancer in ageing populations. Join us online on 03 and 04 December to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 14 October and register before 11 November to secure your place.
Contact:
Conference Officer: Chris Iliffe;     Tél.: [N/A];     Email.: christopher.iliffe@eacr.org
Sujets:
cancer research, oncology, ageing, ageing hallmarks, senescence, immunosenescence, inflammaging, aged tumour microenvironment, cancer prevention, cancer diagnosis, cancer treatment, elderly patients, treatment advances
Identifiant de l'évènement:
1619990
Sujets apparentés:
31
ESMO Asia 2024 — ESMO Asia Congress 2024
06 dec 2024 - 08 dec 2024 • Singapore, Singapour
Organisateur:
ESMO - European Society for Medical Oncology
Résumé:
ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region. ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer. Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.
Contact:
ESMO Asia 2024 Secretariat;     Email.: asiacongress@esmo.org
Sujets:
oncology, translational research, clinical trials, breast cancer, CNS, precision medicine, gastrointestinal tumours, genitourinary tumours, gynecological tumours, haemathological malignancies, head and neck cancers, immunotherapy, melanoma, sarcoma, rare tumours, thoracic cancer, supportive care, palliative care, Clinical Practice Guidelines, radiology
Identifiant de l'évènement:
1616517
32
EACR Systemic Consequences of Cancer: Cancer as a Whole-body Disease
25 fév 2025 - 26 fév 2025 • Online, Virtuel (en ligne)
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Contact:
Conference Officer: Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism
Identifiant de l'évènement:
1620011
Sujets apparentés:
33
DBA25 — EACR Defence is the Best Attack: Immuno-Oncology Breakthroughs
13 mai 2025 - 15 mai 2025 • Barcelona, Espagne
Organisateur:
The European Association for Cancer Research (EACR)
Résumé:
One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.
Contact:
Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org
Sujets:
cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.
Identifiant de l'évènement:
1618024
Sujets apparentés:


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Y'a pas de suivi | Y'a pas de pop-ups | Y'a pas d'animations
Dernière mise à jour: 26 mai 2024